Adrian Rawcliffe

CIK 1555851 · Chief Executive Officer · last filed 2025-12-10

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.04M

Companies

3

Total Filings

49

Lifetime Open-Market Net

-$2.30M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WVE Director 54,700 $5.87 $321.1K -$739.4K 12 2025-12-10
Adaptimmune Therapeutics PLC (ADAP) Delisted Chief Executive Officer 44,327 $0.06 $2.6K -$518.7K 30 2025-02-20
ASND CEO and CFO 3,318 $218.06 $723.5K -$1.04M 7 2019-09-03

Recent Filings · Page 5 of 5

49 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2019-01-16 ASND Sell (S) −3,084 -$16.6K EDGAR
2019-01-08 ASND Grant (A) $0 EDGAR
2018-08-15 WVE Grant (A) $0 EDGAR
2018-03-22 ASND Sell (S) −600,000 -$1.03M EDGAR
2018-01-17 ASND Grant (A) $0 EDGAR
2017-08-17 WVE Grant (A) $0 EDGAR
2017-02-01 WVE Grant (A) $0 EDGAR
2017-01-18 ASND Grant (A) $0 EDGAR
2016-01-20 Adaptimmune Therapeutics PLC (ADAP) Delisted Grant (A) $0 EDGAR
Showing 4149 of 49
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.